NON-INVASIVE BLOOD FLOW ASSESSMENT: Computational Tool for Measuring Arterial Flow From CT
NOVELLA
Computational Tool for Measuring Arterial Flow From CT
1 other identifier
observational
100
1 country
1
Brief Summary
Major invasive surgery, such as oncological abdominal surgery, is associated with a high risk of complications and mortality. One of the main problems in this type of surgery is the difficulty in preserving the arteries and veins necessary to support vital organs. The main objective of this project is to develop software to predict vascular flow changes based on preoperative computed tomography (CT) scans. Currently, the only way to assess preoperative vascular flow is through percutaneous angiography. This is an invasive procedure that requires anaesthesia, hospitalisation, high doses of radiation, vessel manipulation and the possibility of serious injury. It is often used for the diagnosis of vascular stenosis, analysis of vascular flow and preoperative planning to determine which vessels are directly related to organ perfusion. This preoperative planning will be key in the following clinical scenarios:
- 1.Anomalous hepatic artery anatomy in pancreaticoduodenectomy.
- 2.Celiac trunk stenosis.
- 3.Hepatic artery revascularisation from the superior mesenteric artery.
- 4.Hepatic artery flow assessment in liver transplantation.
- 5.Splenic artery flow steal phenomenon in liver transplantation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2023
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2023
CompletedFirst Submitted
Initial submission to the registry
August 12, 2025
CompletedFirst Posted
Study publicly available on registry
September 4, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 30, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2026
ExpectedSeptember 4, 2025
August 1, 2025
2.6 years
August 12, 2025
September 1, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Accuracy of blood flow modification prediction
Compare software's blood flow modification prediction with introperative measurement in each patient.
10 months
Interventions
Intraoperative blood flow measurement
Eligibility Criteria
Patients undergoing pancreaticoduodenectomy for any reason.
You may qualify if:
- Candidates for pancreaticoduodenectomy.
- Good quality preoperative DICOM CT (arterial phase).
- Michel's I arterial configuration.
- Any surgical approach (open or robotic).
- Informed consent.
You may not qualify if:
- Age \< 18 years.
- Technical inability to measure flow.
- GDA infiltration.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital Clínic de Barcelona
Barcelona, Barcelona, 08036, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 12, 2025
First Posted
September 4, 2025
Study Start
September 1, 2023
Primary Completion
March 30, 2026
Study Completion (Estimated)
September 1, 2026
Last Updated
September 4, 2025
Record last verified: 2025-08